Product Launch (Blog)

Dec, 27 2019

Diabetes Pen Market to Witness Market Growth of 7.8% in the Forecast Period of 2019 to 2026

Diabetes Pen Market is forecasted to grow at 7.8% for 2019 to 2026 with factors such as safety issues associated with the usage and strict rules for new products hampering the market growth.

Diabetes pen market has shown a significant adoption rate and preferences from the North American region with countries such as U.S. and Canada. Increasing number of diabetic patients in the region is expected to enhance the demand for the diabetic pen.

Diabetic Pen Market Scenario

According to Data Bridge Market Research the diabetes pen market in developing regions is witnessing a growth in terms of its adoption rate, due to increasing needle stick injury, increasing cases of diabetes, increasing intake of carbohydrates & sugar and changing lifestyle.

Now the question is which are the regions that diabetes pen market players should target? Data Bridge Market Research has forecasted market leaders to target North American developing regions to help them in attaining better volume of revenue generation.

For more analysis on the diabetes pen market, request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-diabetes-pen-market

Diabetes Pen Market Development

Novo Nordisk along with Flex Digital Health announced the launch of their two new connected insulin pens in October 2018. The company will be using Flex's BrightInsight platform in this medical device. The main aim of the launch is to provide customer with better solutions for better diabetic management.

Scope of the Diabetes Pen Market

Diabetes pen market on the basis of countries is divided into U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.

All country based analysis of the diabetes pen market is further analyzed based on maximum granularity into further segmentation. On the basis of indication, diabetes pen market is divided into type I diabetes and type II diabetes. Product type segment of diabetic pen market is segmented into pens and insulin pen needles. Types segment of diabetic pens market is divided into disposable and reusable. Therapy segment of the market is divided into insulin, glucagon-like peptide-1, growth hormones, fertility, osteoporosis, and other.  End- user segment is divided into hospitals, clinics and home care setting.

Diabetes pen is specially designed so that insulin can be injected to the body for the better treatment of diabetes. This is very advantageous for the type 1 diabetic patients. They are highly used by the diabetic pen because they are easy to use and provide less discomfort. Some of the common types of the diabetic pen are disposable and reusable.

To know more about the study https://www.databridgemarketresearch.com/reports/global-diabetes-pen-market

Key Pointers Covered in the Diabetes Pen Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Regulatory Framework and Changes
  • Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • AstraZeneca
  • BD
  • Eli Lilly and Company
  • Biocon
  • Sanofi
  • delfu-medical.com.
  • Owen Mumford.
  • Wockhardt Limited (India)
  • Smiths Group plc
  • P&B Pharmaceuticals Ltd.
  • Nipro Medical Corporation
  • Novo Nordisk India Pvt Ltd
  • Injexuk, Mannkind Corporation
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Copernicus
  • YPSOMED
  • HTL Strefa
  • Merck & Co., Inc.

Above are the key players covered in the report, to know about more and exhaustive list of diabetic pen companies, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-diabetes-pen-market

Research Methodology: Global Diabetes Pen Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/

 


Client Testimonials